Non-myeloablative allogeneic hematopoietic stem cell transplants
Fagioli, F.; Ricchiardi, A.; Carnevale-Schianca, F.
Haematologica 87(8 Suppl): 13-19
2002
ISSN/ISBN: 0390-6078 PMID: 12412384 Document Number: 549822
Document emailed within 1 workday
Related Documents
Siena, S.; Bregni, M.; Di Nicola, M.; Magni, M.; Ravagnani, F.; Gandola, L.; Lombardi, F.; Gianni, A.M. 1996: Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation Tumori 82(2 Suppl): S23-S27Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O. 2002: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87(8): 894-896
Kmonícek, M.; Jebavý, L.; Lánská, M.; Zák, P.; Malý, J.; Maisnar, V. 2000: The treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen Vnitrni Lekarstvi 46(7): 377-383
Chen, Y.; Xu, L-ping.; Liu, D-hong.; Chen, Y-hong.; Han, W.; Shi, H-xia.; Zhang, X-hui.; Wang, J-zhi.; Chen, H.; Liu, K-yan.; Huang, X-jun.; Lu, D-pei. 2007: Donor peripheral stem cells infusion for the treatment of failure of platelet recovery after allogeneic hematopoietic stem cell transplantation Zhonghua Yi Xue Za Zhi 87(14): 964-966
Takase, K.; Miyamoto, T. 2015: Allogeneic hematopoietic stem cell transplantation for multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 73(1): 107-113
Tabbara, I.A.; Kairouz, S.; Nahleh, Z.; Mihalcea, A.Maria. 2003: Current concepts in allogeneic hematopoietic stem cell transplantation Anticancer Research 23(6d): 5055-5067
Kawamoto, T.; Nihei, K.; Doki, N.; Najima, Y.; Kaito, S.; Karasawa, K. 2018: Definitive Radiotherapy for Esophageal Squamous Cell Carcinoma after Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning of Total Body Irradiation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(9): 1357-1359
Hutspardol, S.; Sirachainan, N.; Anurathapan, U.; Pakakasama, S.; Songdej, D.; Chuansumrit, A.; Sirireung, S.; Panthangkool, W.; Hongeng, S. 2013: Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia Journal of the Medical Association of Thailand 96(Suppl 1): S18-S24
Henon, P.R.; Liang, H.; Beck-Wirth, G.; Eisenmann, J.C.; Lepers, M.; Wunder, E.; Kandel, G. 1992: Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants Bone Marrow Transplantation 9(4): 285-291
Kim, M.Y.; Chaudhary, P.; Shulman, I.A.; Pullarkat, V. 2013: Major non-ABO incompatibility caused by anti-Jk(a) in a patient before allogeneic hematopoietic stem cell transplantation Immunohematology 29(1): 11-14
Wang, J.-z.; Liu, D.-h.; Xu, L.-p.; Chen, H.; Liu, K.-y.; Huang, X.-j. 2007: Itraconazole for treatment of fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation Zhonghua Nei Ke Za Zhi 46(1): 29-31
Liu, D.-h.; Chen, S.-s.; Sun, Y.-q.; Wang, J.-z.; Wang, F.-r.; Zhang, X.-h.; Xu, L.-p.; Huang, X.-J. 2013: Clinical characteristics of late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation Zhonghua Nei Ke Za Zhi 52(10): 819-823
Huang, X.-j.; Liu, D.-h.; Xu, L.-p.; Zhang, H.-y.; Liu, K.-y. 2008: Immune-related late-onset hemorrhagic cystitis post allogeneic hematopoietic stem cell transplantation Chinese Medical Journal 121(18): 1766-1769
Yu, Z.-p.; Ding, J.-h.; Chen, B.-a.; Wu, F.; Gao, C.; Sun, Y.-y.; Chen, J.; Zhao, G.; Wang, J.; Li, Y.-f.; Ding, B.-h.; Qian, J. 2011: Analysis of risk factors for relapse of 82 patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation Zhonghua Zhong Liu Za Zhi 33(4): 283-286
Giraud, Géraldine.; Bogdanovic, G.; Priftakis, P.; Remberger, M.; Svahn, B-Marie.; Barkholt, L.; Ringden, O.; Winiarski, J.; Ljungman, P.; Dalianis, T. 2006: The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen Haematologica 91(3): 401-404
Nakai, K.; Mineishi, S.; Kami, M.; Kanda, Y.; Tanosaki, R.; Takaue, Y. 2003: The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch Haematologica 88(1): 115-117
Tang, F.F.; Zhang, X.H.; Chen, H.; Chen, Y.Y.; Han, W.; Wang, J.Z.; Wang, F.R.; Chen, Y.; Huang, X.J.; Xu, L.P. 2017: Surgical treatment of severe, refractory hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation: a report of 17 patients Zhonghua Nei Ke Za Zhi 56(6): 414-418
Hoffman, R. 1995: Human hematopoietic stem cells: potential use as tumor-free autografts after high-dose myeloablative cancer therapy American Journal of the Medical Sciences 309(5): 254-259
Sundin, M.; Le Blanc, K.; Ringdén, O.; Barkholt, L.; Omazic, B.; Lergin, C.; Levitsky, V.; Remberger, M. 2006: The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation Haematologica 91(8): 1059-1067
Armitage, J.O. 1992: Myeloablative regimens in peripheral stem cell transplantation Leukemia 6(Suppl 4): 88-89